Abstract:Objective To explore the possibility of in vivo molecular imaging with MR in the nude mouse model implanted with breast cancer using specific contrast agents,and to evaluate the diagnostic value for breast cancer. Methods The specific contrast agent Gd-DTPA-BSA-chTNT was obtained by conjugating Gd-DTPA-BSA and monoclonal antibody of chTNT under specific conditions.The breast cancer cells of MDA-MB-231 were orthotopically implanted in the five-week-old BALB/c female nude mice(class SPF)to establish the animal model.Twelve nude mice with human breast cancer were randomly divided into the experimental group(n=6)and the control group(n=6).The animals in the experi- mental group were injected with Gd-DTPA-BSA-chTNT via vena caudalis,whereas the routine Gd-DTPA was used in the control group at the same dosage of gadolinium with the same amount of 0.2 ml as the experimental group.The tumor sig- nal intensities(SI)on T1WI were measured at 5 min,1 h,2 h,3h,4h,8 h,12 h and 24 h respectively after injection of contrast agents with the SI of the anterior limb muscles on the same side as control,and then all of the results were statis- tically analyzed.The CNR(contrast to noise ratio)was calculated as well.Results The tumor SI increased remarkably in the experimental group at 1 hour after injection of Gd-DTPA-BSA-chTNT,reached the peak at 4 h,and enhanced persis- tently for more than 24 h.There was a statistical difference on the SI in the experimental group before and after injection of the specific contrast agents(P＜0.001).The SI of the muscles did not increased obviously in all the time and no statisti- cal difference between precontrast and postcontrast imaging(P＞0.05).In comparison with the precontrast imaging,the SI of tumor and muscles in the control group increased greatly at 5 min,1 h,2 h,3 h and 4 h respectively after injection of Gd-DTPA with significant difference(P＜0.001)between the images with and without contrast.And the contrast in the tumors almost entirely washed out at 8 h after injection of Gd-DTPA.Conclusions The in vivo MR imaging investigation of breast cancer in the nude mouse model could be realized by employing the specific contrast agents Gd-DTPA-BSA- chTNT in this study.The contrast agent shows the definite characteristics of tumor targeting effect on human breast cancer orthotopically implanted in the nude mice,and therefore the imaging will be potentially conducive to the detection and characterization of breast cancer.

Development of a New Specific MR Contrast Agent Gd-DTPA-BSA-chTNT and Its Application in Vivo Molecular MR Imaging in the Nude Mouse Model Implanted with Human Breast Cancer

Magnetic resonance molecular imaging of metastatic breast cancer by targeting extradomain-B fibronectin in the tumor microenvironment.

Ultrasound and magnetic resonance imaging of cyclic arginine glycine aspartic acid-gadopentetic acid-polylactic acid in human breast cancer by targeting αvβ3 in xenograft-bearing nude mice

Study on angiogenesis-targeting paramagnetic nanoliposomes in MRI for diagnosis of pulmonary carcinoma

Diagnostic Value of SPIO and Gd-DTPA Enhanced MR Imaging in Nude Mouse Model of Transplanted Renal Carcinoma

Study of Distribution and Antisense Imaging for 99Mtc-Ason-egf in Breast Cancer-Bearing Nude Mouse Models

Visualization of Tumor Angiogenesis Using MR Imaging Contrast Agent Gd-DTPA-anti-VEGF Receptor 2 Antibody Conjugate in a Mouse Tumor Model

Lung Neoplasm Targeted Nanotechnology MR Contrast Medium: Experimental Study of Mice Model

A Targeted Nanoglobular Contrast Agent from Host-Guest Self-Assembly for MR Cancer Molecular Imaging.

Radioimmunolocalization and blodistribution of 131Ⅰ labeled anti-CEA,TPS and mixture monoclonal antibody in nude mice bearing human breast cancer xenografts

Preparation of 68Ga-Dota-cngr and Its Application in Imaging of the Nude Mice Bearing Human Lung Cancer

In vivo studies of Gd-DTPA-monoclonal antibody and gd-porphyrins: potential magnetic resonance imaging contrast agents for melanoma

A Dual Ligand Targeted Nanoprobe with High MRI Sensitivity for Diagnosis of Breast Cancer

Lymph Node Metastases Detection Using Gd2O3@PCD as Novel Multifunctional Contrast Imaging Agent in Metabolic Magnetic Resonance Molecular Imaging

Construction of RGD10-NGR9 Dual-Targeting Superparamagnetic Iron Oxide and Its Magnetic Resonance Imaging Features in Nude Mice

Experimental Research of ~(99)Tc~m-MIBI SPECT in Detecting Multidrug Resistance Status on Tumor Nude Mice

The Cam Cancer Xenograft As A Model for Initial Evaluation of Mr Labelled Compounds

MR Imaging of Tumor Angiogenesis Using Sterically Stabilized Gd-DTPA Liposomes Targeted to CD105.

Intracellular Construction of Cathepsin B-Guided Gadolinium Nanoparticles for Enhanced T2 -Weighted MR Tumor Imaging.

Molecular Imaging for PET-CT Reporter Gene in Breast Adenocarcinoma (Hsv1-Tk) of Subcutaneous Xenografts in Living Nude Mice